MEF2C and chronic myelogenous leukemia, BCR-ABL1 positive: The expression of miR-181a in hematopoietic stem and progenitor cells regulates the development of blood cells.   37  BCR-ABL mediated suppression of miR-223 leads to activation of MEF2C and PTBP2 in CML.